Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

@article{Miller2011TriglyceridesAC,
  title={Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.},
  author={Michael Miller and N. Stone and C. Ballantyne and V. Bittner and M. Criqui and H. Ginsberg and A. Goldberg and W. Howard and M. Jacobson and P. Kris-Etherton and T. Lennie and M. Levi and T. Mazzone and Subramanian Pennathur},
  journal={Circulation},
  year={2011},
  volume={123 20},
  pages={
          2292-333
        }
}
A long-standing association exists between elevated triglyceride levels and cardiovascular disease* (CVD).1,2 However, the extent to which triglycerides directly promote CVD or represent a biomarker of risk has been debated for 3 decades.3 To this end, 2 National Institutes of Health consensus conferences evaluated the evidentiary role of triglycerides in cardiovascular risk assessment and provided therapeutic recommendations for hypertriglyceridemic states.4,5 Since 1993, additional insights… Expand

Paper Mentions

News Article
Interventional Clinical Trial
The primary objetive was to evaluate the safety and efficacy the 3 grams per day of omega-3 in adolescents with obesity and hypertriglyceridemia ( ≥ 150 mg/dl and ≤ 1000 mg/dl) for 12… Expand
ConditionsHypertriglyceridemia, Pediatric Obesity
InterventionDietary Supplement
Interventional Clinical Trial
Many patients complain of fishy breath, upset stomach, or heartburn when taking the recommended amount of fish oil. A common recommendation made by pharmacists is to freeze the… Expand
ConditionsAdverse Effects
InterventionDietary Supplement
Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?
TLDR
In this issue of Cardiology, Kim et al. report that, based upon a very large cohort of 86,476 Korean people, elevated TGs are indeed independently associated with an increased risk for CVD, especially in non-obese, normotensive or non-diabetic individuals. Expand
APOC3: Triglycerides do matter
  • M. Hassan
  • Medicine
  • Global cardiology science & practice
  • 2014
TLDR
Data from the TG and HDL Working Group of the Exome Sequencing Project provide insights into the association between APOC3 genotype, plasma lipid profile, and risk of clinical CHD. Expand
Lessons from the trials APOC 3 : Triglycerides do matter
INTRODUCTION Obesity, insulin resistance, and metabolic syndrome are escalating problems in developed and developing countries. High plasma triglyceride (TG) levels are commonly encountered inExpand
Does lowering triglycerides reduce cardiovascular risk?
  • J. P. Moura
  • Medicine
  • Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • 2019
TLDR
Non-fasting TG levels may be a better indicator of mean lipid concentrations in the blood, and individuals are exposed to post-prandial TG most of the time, as most people eat regularly throughout the day. Expand
The Role of Triglycerides in Atherosclerosis
TLDR
The role of hypertriglyceridemia and its associated atherogenic lipoproteins in the pathogenesis of atherosclerosis, the relevance of a high TG level as a predictor of CVD, the cardiovascular outcomes from TG-lowering intervention trials, and the current guidelines for treating hypertrigonidemia are reviewed. Expand
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
  • P. Toth
  • Medicine
  • Vascular health and risk management
  • 2016
TLDR
Evidence suggests that non-high-density lipoprotein cholesterol, the sum of the total cholesterol carried by atherogenic lipoproteins (including LDL, TRL, and TRL remnants), provides a better indication of CVD risk than LDL-C, particularly in patients with hypertriglyceridemia. Expand
The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
  • S. Tani
  • Medicine
  • Internal medicine
  • 2020
TLDR
In demonstrating its usefulness, Moriyama showed that the TG/HDL-C ratio can be easily estimated even in clinical settings using combined serum small-dense LDL and malondialdehyde-modified LDL, representing atherogenic LDL subclasses, and supports the possibility of applying the TG /HDL/C ratio as a new management target for the prevention of ASCVD. Expand
Lipids in Coronary Heart Disease: From Epidemiology to Therapeutics
TLDR
The epidemiology of the major lipid fractions with ASCVD risk is reviewed, therapeutic interventions from lifestyle and pharmacologic therapies are discussed, and promising areas of translational research are highlighted for future drug developments for the management of patients with or at high-risk for coronary artery disease. Expand
Low-Density Lipoprotein Triglycerides: Widening the Atherogenic Landscape in CVD Risk Assessment.
  • Michael Miller
  • Medicine
  • Journal of the American College of Cardiology
  • 2018
TLDR
The present study widens the atherogenic landscape by finding RLPs and LDL-TG to be independently associated with incident CVD even after adjustment for traditional risk factors. Expand
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
Circulation Research is available at http://circres.ahajournals.org DOI: 10.1161/CIRCRESAHA.115.306249 Abstract: Scientific interest in triglyceride-rich lipoproteins has fluctuated over the pastExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 561 REFERENCES
Apolipoprotein CIII: a link between hypertriglyceridemia and vascular dysfunction?
TLDR
Post hoc analysis of statin trials, such as PROVE-IT TIMI 22, have identified plasma triglycerides as a determinant of cardiovascular risk in patients achieving LDL-cholesterol goals. Expand
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
TLDR
Regulating apoC-III metabolism may be an important new therapeutic approach to managing dyslipidaemia and CVD risk in the metabolic syndrome, and experimental evidence shows that it may also have a direct role in atherosclerosis. Expand
Triglyceride, high density lipoprotein, and coronary heart disease.
TLDR
A consensus panel weighed the evidence and prepared their consensus statement, finding that existing data provide considerable support for a causal relationship between low HDL and CHD and there is a strong consensus that hygienic approaches should be employed to lower TG and/or raise HDL. Expand
Relation of triglyceride levels to coronary artery disease: the Milwaukee Cardiovascular Data Registry.
TLDR
The results indicate that the association between coronary artery occlusion and levels of triglycerides is indirect, and that the disparate findings of earlier studies may have resulted from not controlling for HDL cholesterol. Expand
Plasma triglyceride level and mortality from coronary heart disease.
TLDR
Overall, the plasma triglyceride level showed no independent association with coronary mortality, but in subgroups of subjects with lower HDL and LDL cholesterol levels and in younger subjects, defined a priori, an association was observed, although this association was small and was not statistically significant after an adjustment for the plasma glucose level. Expand
Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.
TLDR
The data indicate that fasting triglycerides, as a marker for triglyceride-rich lipoproteins, may provide valuable information about the atherogenic potential of the lipoprotein profile, particularly when considered in context of HDL levels. Expand
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
TLDR
The metabolic syndrome, as defined by ATP III, incorporates a number of the components of these syndromes, including insulin resistance and intra-abdominal fat, and appears to be part of this atherogenic syndrome. Expand
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.
TLDR
It is concluded that triglycerides are independent predictors of CAD in multivariate analyses including HDL cholesterol, provided that a challenge test of triglyceride metabolism such as postprandial lipemia is used. Expand
Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals.
TLDR
Non-HDL-C was more strongly associated with subclinical atherosclerosis than all other conventional lipid values and may be an important treatment target in primary prevention. Expand
Diabetic dyslipidemia.
TLDR
Although gemfibrozil (fibric acid derivative) is more effective in decreasing triglycerides and increasing HDL cholesterol in diabetic patients than the statins, it does not change and may even increase LDL-cholesterol levels (fenofibrate may be an exception, decreasing LDL cholesterol by 20-25% in some studies). Expand
...
1
2
3
4
5
...